Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma.

Ana FloreaRobin B HarrisYann C KlimentidisLindsay N KohlerPeter W JurutkaElizabeth T Jacobs

Published in: Journal of gastrointestinal cancer (2020)

Our results reveal for the first time that, in addition to a recently discovered association with colorectal cancer, circulating FGF-21 concentrations are significantly and directly associated with odds of developing metachronous colorectal adenoma.

Keyphrases

genome wide
single cell